274 related articles for article (PubMed ID: 1495977)
21. Homologous recombination in hybridoma cells: heavy chain chimeric antibody produced by gene targeting.
Fell HP; Yarnold S; Hellström I; Hellström KE; Folger KR
Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8507-11. PubMed ID: 2510167
[TBL] [Abstract][Full Text] [Related]
22. Structure and specificity of a class II MHC alloreactive gamma delta T cell receptor heterodimer.
Matis LA; Fry AM; Cron RQ; Cotterman MM; Dick RF; Bluestone JA
Science; 1989 Aug; 245(4919):746-9. PubMed ID: 2528206
[TBL] [Abstract][Full Text] [Related]
23. The transmembrane orientation of the epsilon chain of the TcR/CD3 complex.
Clevers H; Dunlap S; Terhorst C
Eur J Immunol; 1988 May; 18(5):705-10. PubMed ID: 2967760
[TBL] [Abstract][Full Text] [Related]
24. Expression of human T cell receptor-gamma delta structural forms.
Band H; Hochstenbach F; Parker CM; McLean J; Krangel MS; Brenner MB
J Immunol; 1989 May; 142(10):3627-33. PubMed ID: 2785559
[TBL] [Abstract][Full Text] [Related]
25. Systematic development of distinct T cell receptor-gamma delta T cell subsets during fetal ontogeny.
Houlden BA; Cron RQ; Coligan JE; Bluestone JA
J Immunol; 1988 Dec; 141(11):3753-9. PubMed ID: 3263433
[TBL] [Abstract][Full Text] [Related]
26. Identification of a second T-cell antigen receptor in human and mouse by an anti-peptide gamma-chain-specific monoclonal antibody.
Ioannides CG; Itoh K; Fox FE; Pahwa R; Good RA; Platsoucas CD
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4244-8. PubMed ID: 2438695
[TBL] [Abstract][Full Text] [Related]
27. Functional assembly of chimeric T-cell receptor chains.
Gorochov G; Lustgarten J; Waks T; Gross G; Eshhar Z
Int J Cancer Suppl; 1992; 7():53-7. PubMed ID: 1428405
[TBL] [Abstract][Full Text] [Related]
28. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
Flood PM
J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
[TBL] [Abstract][Full Text] [Related]
29. [Construction of expression vector for human-mouse chimeric antibody and expression of an antibody against human HER2].
Wang LL; Han H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):363-5. PubMed ID: 15193240
[TBL] [Abstract][Full Text] [Related]
30. Design and construction of a hybrid immunoglobulin domain with properties of both heavy and light chain variable regions.
Ill CR; Gonzales JN; Houtz EK; Ludwig JR; Melcher ED; Hale JE; Pourmand R; Keivens VM; Myers L; Beidler K; Stuart P; Cheng S; Radhakrishnan R
Protein Eng; 1997 Aug; 10(8):949-57. PubMed ID: 9415445
[TBL] [Abstract][Full Text] [Related]
31. Heat shock protein Hsp60-reactive gamma delta cells: a large, diversified T-lymphocyte subset with highly focused specificity.
O'Brien RL; Fu YX; Cranfill R; Dallas A; Ellis C; Reardon C; Lang J; Carding SR; Kubo R; Born W
Proc Natl Acad Sci U S A; 1992 May; 89(10):4348-52. PubMed ID: 1584768
[TBL] [Abstract][Full Text] [Related]
32. T-cell receptor gamma delta diversity and specificity of intestinal intraepithelial lymphocytes: analysis of IEL-derived hybridomas.
Sydora BC; Mixter PF; Houlden B; Hershberg R; Levy R; Comay M; Bluestone J; Kronenberg M
Cell Immunol; 1993 Dec; 152(2):305-22. PubMed ID: 8258140
[TBL] [Abstract][Full Text] [Related]
33. Specificity for molecules of the major histocompatibility complex mediated by a hybrid immunoglobulin-T cell receptor.
Kawasaki H; Becker ML; Hedrick SM
New Biol; 1991 May; 3(5):487-97. PubMed ID: 1715754
[TBL] [Abstract][Full Text] [Related]
34. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
[TBL] [Abstract][Full Text] [Related]
35. Cloning, expression, and crystallization of the V delta domain of a human gamma delta T-cell receptor.
Lebedeva MI; Fields BA; Spits H; Panchamoorthy G; Brenner MB; Mariuzza RA
Protein Sci; 1996 Dec; 5(12):2638-42. PubMed ID: 8976572
[TBL] [Abstract][Full Text] [Related]
36. Major histocompatibility complex determinants select T-cell receptor alpha chain variable region dominance in a peptide-specific response.
Natarajan K; Burstyn D; Zauderer M
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8874-8. PubMed ID: 1384036
[TBL] [Abstract][Full Text] [Related]
37. Self heat shock and gamma delta T-cell reactivity.
Rajasekar R; Sim GK; Augustin A
Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1767-71. PubMed ID: 2106682
[TBL] [Abstract][Full Text] [Related]
38. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
39. Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody.
Couto JR; Blank EW; Peterson JA; Ceriani RL
Hybridoma; 1993 Feb; 12(1):15-23. PubMed ID: 8454302
[TBL] [Abstract][Full Text] [Related]
40. Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins.
Slavin-Chiorini DC; Kashmiri SV; Schlom J; Calvo B; Shu LM; Schott ME; Milenic DE; Snoy P; Carrasquillo J; Anderson K
Cancer Res; 1995 Dec; 55(23 Suppl):5957s-5967s. PubMed ID: 7493377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
